Dr. Sarvesh Logsetty, MD
Claim this profileUniversity of Manitoba
Studies Burns
Studies Scar
7 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Sarvesh Logsetty, MD is currently running
PluroGel vs Standard Dressing
for Burns
Burn injuries can result in long term physical and mental sequelae, not only from the scarring but also the painful dressings. The standard of care today remains use of antibiotic topical dressings while awaiting demarcation of the burn depth, with surgical excision and grafting for deep partial thickness and full thickness areas. Demarcation can be appreciated on admission for full thickness burns but is often a prolonged process that can last weeks. The clinical evaluation of the depth of the burn is a complex decision that often is made more challenging by the presence of the proteinaceous pseudoeschar and the coagulated dermis itself. Surgical debridement is relatively 'coarse' and by its very nature requires removal of a thin layer of viable tissue to reach the level that is vascularized enough to support a skin graft. There has been growing interest in the use of adjuncts to reduce the amount tissue debrided and potentially reduce the need for surgery itself. Operatively, there have been some reports that use of hydro-dissection devices (Versajet™) may allow a more controlled debridement, resulting in less viable tissue being sacrificed. There is also a growing experience with enzymatic debridement, especially with Bromolein, derived from Pineapple (NexoBrid®). Neither of these have been shown to definitively improve care in randomized controlled trials, (RCTs) and there is suggestion that in some settings may actually cause harm.
Recruiting1 award Phase 1 & 2
Phenylephrine
for Blood Loss in Burn Surgery
The standard of care for treatment of burn injury is to inject a solution of epinephrine under the skin of the injured site in order to reduce blood loss during skin grafting. This solution of epinephrine has been shown to have effects on the body outside the donor site. Some people have increases in heart rate and blood pressure. We will study the effect of a phenylephrine solution in place of an epinephrine solution to control blood loss. We think that phenylephrine will help decrease blood loss and not change blood pressure or heart rate. The injured area will be injected under the skin and a skin graft will be taken in the same way as we usually do. The only change will be the use of phenylephrine in the solution instead of epinephrine. Our goal is to find whether or not phenylephrine or epinephrine solution results in a reduction of blood loss without affecting the rest of the body.
Recruiting1 award Phase 1
More about Sarvesh Logsetty, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Sarvesh Logsetty, MD has experience with
- PluroGel
- Standard Dressing
- Phenylephrine
- Nitrous Oxide Inhalant Product
- Placebo
- Fractional Vascular Laser
Breakdown of trials Sarvesh Logsetty, MD has run
Burns
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sarvesh Logsetty, MD specialize in?
Sarvesh Logsetty, MD focuses on Burns and Scar. In particular, much of their work with Burns has involved treating patients, or patients who are undergoing treatment.
Is Sarvesh Logsetty, MD currently recruiting for clinical trials?
Yes, Sarvesh Logsetty, MD is currently recruiting for 7 clinical trials in Winnipeg Manitoba. If you're interested in participating, you should apply.
Are there any treatments that Sarvesh Logsetty, MD has studied deeply?
Yes, Sarvesh Logsetty, MD has studied treatments such as PluroGel, Standard dressing, Phenylephrine.
What is the best way to schedule an appointment with Sarvesh Logsetty, MD?
Apply for one of the trials that Sarvesh Logsetty, MD is conducting.
What is the office address of Sarvesh Logsetty, MD?
The office of Sarvesh Logsetty, MD is located at: University of Manitoba, Winnipeg, Manitoba R3A 1R9 Canada. This is the address for their practice at the University of Manitoba.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.